An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
NCT01101048
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
74
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteopenia
Interventions
DRUG:
Placebo
DRUG:
AMG 167
Sponsor
Amgen